Alaunos Therapeutics Inc (TCRT)
2.05
+0.03
(+1.50%)
USD |
NASDAQ |
Oct 31, 16:00
2.00
-0.05
(-2.44%)
After-Hours: 20:00
Alaunos Therapeutics Revenue (Quarterly): 0.004M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.004M |
| March 31, 2024 | 0.001M |
| December 31, 2023 | 0.001M |
| September 30, 2023 | |
| June 30, 2023 | 0.004M |
| March 31, 2023 | |
| December 31, 2022 | 0.011M |
| September 30, 2022 | 2.911M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | 0.398M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.146M |
| December 31, 2017 | 1.597M |
| September 30, 2017 | 1.598M |
| June 30, 2017 | 1.597M |
| March 31, 2017 | 1.597M |
| December 31, 2016 | 1.597M |
| September 30, 2016 | 1.598M |
| June 30, 2016 | 1.697M |
| March 31, 2016 | 1.969M |
| December 31, 2015 | 1.919M |
| September 30, 2015 | 1.869M |
| June 30, 2015 | 0.272M |
| March 31, 2015 | 0.272M |
| December 31, 2014 | 0.34M |
| September 30, 2014 | 0.633M |
| June 30, 2014 | 0.20M |
| March 31, 2014 | 0.20M |
| December 31, 2013 | 0.20M |
| September 30, 2013 | 0.20M |
| June 30, 2013 | 0.20M |
| March 31, 2013 | 0.20M |
| December 31, 2012 | 0.20M |
| September 30, 2012 | 0.20M |
| June 30, 2012 | 0.20M |
| March 31, 2012 | 0.20M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.001M
Minimum
Dec 2023
2.911M
Maximum
Sep 2022
0.4757M
Average
0.004M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Oragenics Inc | -- |
| Cocrystal Pharma Inc | -- |
| Cara Therapeutics Inc | 0.991M |
| Jaguar Health Inc | 2.721M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.129M |
| Total Expenses (Quarterly) | 1.17M |
| EPS Diluted (Quarterly) | -0.71 |
| Enterprise Value | 0.7713M |
| Profit Margin (Quarterly) | -28.22K% |
| Earnings Yield | -619.9% |
| Normalized Earnings Yield | -436.52 |